Page last updated: 2024-08-22

trolamine salicylate and Erythroderma, Sezary

trolamine salicylate has been researched along with Erythroderma, Sezary in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuzumi, A; Miyagaki, T; Mukogawa, S; Sato, S; Takahashi-Shishido, N1
Bálint, G; Breier, F; Graninger, W; Jantschitsch, C; Kainberger, F; Knobler, RM; Macheiner, W; Marschalkó, M; Pálóczy, K1
del Río Garma, J; Galdo Fernández, F; Gómez Rodríguez, N; Graña Gil, J; Sánchez Bursón, JM; Yebra Pimentel, MT1
Billström, R; Dybjer, A; Hellquist, L; Johansson, B; Rydgren, L1

Reviews

1 review(s) available for trolamine salicylate and Erythroderma, Sezary

ArticleYear
[Asymmetric polyarthritis in Sézary's syndrome].
    Revista clinica espanola, 1993, Volume: 192, Issue:2

    Topics: Aged; Arthritis; Arthritis, Psoriatic; Biopsy; Chronic Disease; Female; Humans; Sezary Syndrome; Skin; Skin Neoplasms; Synovial Membrane

1993

Other Studies

3 other study(ies) available for trolamine salicylate and Erythroderma, Sezary

ArticleYear
Paraneoplastic arthritis in a patient with Sézary syndrome.
    International journal of dermatology, 2018, Volume: 57, Issue:8

    Topics: Arthritis; Contracture; Female; Finger Joint; Humans; Middle Aged; Paraneoplastic Syndromes; Sezary Syndrome; Wrist Joint

2018
Sézary syndrome and seronegative polyarthritis: treatment with extracorporeal photochemotherapy.
    Journal of the American Academy of Dermatology, 2003, Volume: 48, Issue:2

    Topics: Arthritis; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Humans; Lymphocyte Count; Male; Middle Aged; Photopheresis; Radiography; Sezary Syndrome; Skin Neoplasms

2003
Seropositive polyarthritis and skin manifestations in T-prolymphocytic leukemia/Sezary cell leukemia variant.
    Leukemia & lymphoma, 2000, Volume: 37, Issue:3-4

    Topics: Arthritis; Fatal Outcome; Humans; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Middle Aged; Sezary Syndrome

2000